Please assess the completion status of the following clinical trial:

Trial Title: Patient Reported Outcome Measures (PROMs) With Trabectedin

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* This study will include adult patients treated in Leeds with an indication for Trabectedin as either second or third line therapy for relapsed soft tissue sarcoma.~* Patients will have the ability to provide informed consent and they will have adequate literacy in reading English, or complete the instrument using an NHS interpreter.~Exclusion Criteria:~* No exclusion criteria

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: 130 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).